Skip to Main Content

Paper Details

eIF2β, a subunit of translation-initiation factor EIF2, is a potential therapeutic target for non-small cell lung cancer.
Cancer Sci
18
2018
Author NameAffiliation
John D MinnaHamon Center for Therapeutic Oncology Research, Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center
Kevin R CoombesOhio State University
  • 1 - 2

Datasets

Release 1.2